Single Biggest Cancer Dictionary in the World

What is anti-CD27 monoclonal antibody GEN1053/BNT313?

Pronunciation: /ˈænˌti ˈsiˈdi twenty-seven* ˌmɑnəˈkloʊnəl ˈæntɪˌbɑdi ʤɛn wən ˈθaʊzənd ənd fifty-three* bnt* θri ˈhənərd ənd ˈθərˈtin/

anti-CD27 monoclonal antibody GEN1053/BNT313

Definition

A monospecific hexamer-forming antibody, based on the HexaBody technology platform, directed against the cell surface antigen CD27, with potential immunostimulatory and antineoplastic activities. Upon administration, anti-CD27 monoclonal antibody GEN1053/BNT313 targets and binds to CD27 expressed on a variety of immune cell types, including most T lymphocytes, and forming a hexamer upon binding. This induces CD27-mediated signaling, and enhances CD27-mediated responses, including the expansion of antigen-activated T cells and natural killer (NK) cells. This restores immune function and leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells. CD27, a co-stimulatory molecule and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on T lymphocytes, memory B cells and NK cells. It plays an important role in NK cell-mediated cytolytic activity and T- and B-lymphocyte proliferation and activation.